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Regulation of Biotechnology 
Greg Simon (Letters, 3 May, p. 629) 
makes the case that only federal regulation 
of releases of agricultural products will ad- 
dress health and safety concerns. Such a view 
is hardly surprising, since he drafted the 
federal statute for the comprehensive regu- 
lation of field research with recombinant 
DNA-manipulated organisms. The basic as- 
sumptions of this statute were contrary to 
those contained in the reports of the ~ a u o n -  
al Academy of Sciences (NAS) (1) and the 
National Research Council (NRC) (2) and 
also to the existing policies of government 
research and regulatory agencies. The stat- 
ute would have regulated only those orga- 
nisms that were manipulated with recombi- 
nant DNA techniques (and virtually all of 
them), but not organisms likely to be of 
high risk, such as those possessing enhanced 
fitness or pathogenicity or those that contain 
novel phenotypes. Such a statute would not 
have allayed public fears or conferred safety 
protection above that of current regulation, 
but it would have perpetuated the notion 
that process, rather than performance or 
should be the focus of regulation. 
It would, inevitably, have exerted a chilling 
effect on those wishing to use the newest 
techniques. This scientifically indefensible 
approach was criticized by government 
agencies, industry, and academia alike and 
was rejected by Congress. 
Simon criticizes the congruence of the 
principles underlying our proposal (Policy 
Forum, 26 Oct., p. 490) with those elabo- 
rated in reports from the NAS and the 
NRC. He criticizes us for not relying instead 
on a position paper by the Ecological Soci- 
ety of America (ESA) ( 3 ) .  We believe the 
NAS-NRC principles are scientifically de- 
fensible and internally consistent but that 
the statements of the ESA, which are depen- 
dent on process, are not. The ESA paper 
agreed with the NAS and NRC that there is 
no fundamental difference between new and 
old techniques of genetic manipulation with 
respect to risk for organisms used in field 
trials, but it concluded that every proposed 
field trial of an organism manipulated with 
recombinant DNA techniques-without 
any expression or exemption-must be sub- 
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jected to a governmental risk assessment. 
However, agricultural research even with 
plants or microbes that have been powerful- 
ly modified by a variety of traditional genetic 
techniques, has not been routinely subject to 
governmental "case by case every case" eval- 
uation, except for certain plant pests, nox- 
ious weeds, or organisms considered to be 
veterinary vaccines. And when one considers 
that an individual plant breeder "may intro- 
duce into the field 50,000 genotypes per 
year on average or 2,000,000 in a career" (2, 
p. 66), and that many of these are trans- 
genic, it is dear that the logic of the ESAYs 
position is flawed (4). 
Simon cites what he considers to be an- 
other contradiction between the NAS-NRC 
reports and the ESA paper, noting the NAS- 
NRC conclusion that intergeneric orga- 
nisms present no unique hazards per se and 
that most engineered organisms are expect- 
ed to be less fit than their parental orga- 
nisms. He continues, "Conversely, [the ESA 
report] predicts that '[o]rganisms with novel 
combinations of traits are more likely to play 
novel ecological roles.' " These statements 
are not necessarily incompatible. An inter- 
generic organism may not represent a "novel 
combination of traits" with respect to eco- 
logical, genetic, or even phenotypic factors. 
Conversely, intrageneric genetic changes can 
confer changes that exert drastic effects. As 
we emphasized one must consider carehlly 
theji4nction of coding or regulatory elements 
that have been transferred; less important is 
the technique used to confer the genetic 
change or the presumed evolutionary dis- 
tance between the nucleic acids being re- 
combined. 
Simon characterizes our proposal as "too 
little" and derides it as "self-redation." 
A d y ,  it provides an algorithmw that has 
unlimited flexibility. Depending on what is 
judged to be an acceptable regulatory bur- 
den on mearchers and the government, an 
appropriate level of scrutiny for certain or- 
ganisms, and other factors, the mechanism 
can vary widely-fiom an extremely strin- 
gent scheme with a high proportion of 
required case-by-case governmental risk as- 
sessments to a more laissez-faire one in 
which there is complete exemption or a 
requirement only for notification for the 
majority of experiments. Whatever the 
choice, the cardinal principles of sound reg- 
ulation would be met. 
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